Literature DB >> 21593158

A Tyr residue in the reverse transcriptase domain can mimic the protein-priming Tyr residue in the terminal protein domain of a hepadnavirus P protein.

Jürgen Beck1, Michael Nassal.   

Abstract

Hepadnaviruses are the only known viruses that replicate by protein-primed reverse transcription. Beyond the conserved reverse transcriptase (RT) and RNase H domains, their polymerases (P proteins) carry a unique terminal protein (TP) domain that provides a specific Tyr residue, Tyr96 in duck hepatitis B virus (DHBV), to which the first nucleotide of minus-strand DNA is autocatalytically attached and extended by three more nucleotides. In vitro reconstitution of this priming reaction with DHBV P protein and cellular chaperones had revealed strict requirements for the Dε RNA stem-loop as a template and for catalytic activity of the RT domain plus RNA-binding competence of the TP domain. Chaperone dependence can be obviated by using a truncated P protein (miniP). Here, we found that miniP with a tobacco etch virus (TEV) protease cleavage site between TP and RT (miniP(TEV)) displayed authentic priming activity when supplied with α-(32)P-labeled deoxynucleoside triphosphates; however, protease cleavage revealed, surprisingly, that the RT domain was also labeled. RT labeling had identical requirements as priming at Tyr96 and originated from dNMP transfer to a unique Tyr residue identified as Tyr561 in the presumed RT primer grip motif. Mutating Tyr561 did not affect Tyr96 priming in vitro and only modestly reduced replication competence of an intact DHBV genome; hence, deoxynucleotidylated Tyr561 is not an obligate intermediate in TP priming. However, as a first alternative substrate for the exquisitely complex protein-priming reaction, dNMP transfer to Tyr561 is a novel tool to further clarify the mechanism of hepadnaviral replication initiation and suggests that specific priming inhibitors can be found.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21593158      PMCID: PMC3147918          DOI: 10.1128/JVI.00482-11

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  61 in total

Review 1.  Pattern recognition of viral nucleic acids by RIG-I-like helicases.

Authors:  Andreas Schmidt; Stefan Endres; Simon Rothenfusser
Journal:  J Mol Med (Berl)       Date:  2010-09-04       Impact factor: 4.599

2.  The phi29 DNA polymerase:protein-primer structure suggests a model for the initiation to elongation transition.

Authors:  Satwik Kamtekar; Andrea J Berman; Jimin Wang; José M Lázaro; Miguel de Vega; Luis Blanco; Margarita Salas; Thomas A Steitz
Journal:  EMBO J       Date:  2006-03-02       Impact factor: 11.598

Review 3.  Refolding solubilized inclusion body proteins.

Authors:  Richard R Burgess
Journal:  Methods Enzymol       Date:  2009       Impact factor: 1.600

4.  Molecular modeling and biochemical characterization reveal the mechanism of hepatitis B virus polymerase resistance to lamivudine (3TC) and emtricitabine (FTC).

Authors:  K Das; X Xiong; H Yang; C E Westland; C S Gibbs; S G Sarafianos; E Arnold
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

5.  Efficient Hsp90-independent in vitro activation by Hsc70 and Hsp40 of duck hepatitis B virus reverse transcriptase, an assumed Hsp90 client protein.

Authors:  Jürgen Beck; Michael Nassal
Journal:  J Biol Chem       Date:  2003-07-08       Impact factor: 5.157

6.  Chaperones activate hepadnavirus reverse transcriptase by transiently exposing a C-proximal region in the terminal protein domain that contributes to epsilon RNA binding.

Authors:  Michael Stahl; Jürgen Beck; Michael Nassal
Journal:  J Virol       Date:  2007-10-03       Impact factor: 5.103

7.  Hepatitis B virus reverse transcriptase and epsilon RNA sequences required for specific interaction in vitro.

Authors:  Jianming Hu; Morgan Boyer
Journal:  J Virol       Date:  2006-03       Impact factor: 5.103

8.  Hepadnavirus P protein utilizes a tyrosine residue in the TP domain to prime reverse transcription.

Authors:  M Weber; V Bronsema; H Bartos; A Bosserhoff; R Bartenschlager; H Schaller
Journal:  J Virol       Date:  1994-05       Impact factor: 5.103

9.  Reverse transcription of the pFOXC mitochondrial retroplasmids of Fusarium oxysporum is protein primed.

Authors:  Jeffrey T Galligan; Sarah E Marchetti; John C Kennell
Journal:  Mob DNA       Date:  2011-01-21

10.  LOMETS: a local meta-threading-server for protein structure prediction.

Authors:  Sitao Wu; Yang Zhang
Journal:  Nucleic Acids Res       Date:  2007-05-03       Impact factor: 16.971

View more
  18 in total

1.  Conservation of the HBV RNA element epsilon in nackednaviruses reveals ancient origin of protein-primed reverse transcription.

Authors:  Jürgen Beck; Stefan Seitz; Chris Lauber; Michael Nassal
Journal:  Proc Natl Acad Sci U S A       Date:  2021-03-30       Impact factor: 11.205

2.  In vitro epsilon RNA-dependent protein priming activity of human hepatitis B virus polymerase.

Authors:  Scott A Jones; Rajeev Boregowda; Thomas E Spratt; Jianming Hu
Journal:  J Virol       Date:  2012-02-29       Impact factor: 5.103

3.  Large-scale production and structural and biophysical characterizations of the human hepatitis B virus polymerase.

Authors:  Judit Vörös; Annika Urbanek; Gilles Jean Philippe Rautureau; Maggie O'Connor; Henry C Fisher; Alison E Ashcroft; Neil Ferguson
Journal:  J Virol       Date:  2013-12-18       Impact factor: 5.103

4.  Mapping of Functional Subdomains in the Terminal Protein Domain of Hepatitis B Virus Polymerase.

Authors:  Daniel N Clark; John M Flanagan; Jianming Hu
Journal:  J Virol       Date:  2017-01-18       Impact factor: 5.103

5.  Carbonyl J acid derivatives block protein priming of hepadnaviral P protein and DNA-dependent DNA synthesis activity of hepadnaviral nucleocapsids.

Authors:  Yong-Xiang Wang; Yu-Mei Wen; Michael Nassal
Journal:  J Virol       Date:  2012-07-11       Impact factor: 5.103

6.  Cryptic protein priming sites in two different domains of duck hepatitis B virus reverse transcriptase for initiating DNA synthesis in vitro.

Authors:  Rajeev K Boregowda; Li Lin; Qin Zhu; Fang Tian; Jianming Hu
Journal:  J Virol       Date:  2011-05-18       Impact factor: 5.103

7.  TP-RT domain interactions of duck hepatitis B virus reverse transcriptase in cis and in trans during protein-primed initiation of DNA synthesis in vitro.

Authors:  Rajeev K Boregowda; Christina Adams; Jianming Hu
Journal:  J Virol       Date:  2012-04-18       Impact factor: 5.103

8.  Protein-primed terminal transferase activity of hepatitis B virus polymerase.

Authors:  Scott A Jones; Jianming Hu
Journal:  J Virol       Date:  2012-12-19       Impact factor: 5.103

Review 9.  Hepatitis B virus reverse transcriptase - Target of current antiviral therapy and future drug development.

Authors:  Daniel N Clark; Jianming Hu
Journal:  Antiviral Res       Date:  2015-09-25       Impact factor: 5.970

10.  Identification and characterization of a novel bipartite nuclear localization signal in the hepatitis B virus polymerase.

Authors:  Joachim Lupberger; Stephanie Schaedler; Alexander Peiran; Eberhard Hildt
Journal:  World J Gastroenterol       Date:  2013-11-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.